127 related articles for article (PubMed ID: 31565203)
1. DNMT3B-579G>T (rs1569686G>T) polymorphism and the risk of multiple sclerosis in a subset of Iranian population.
Yazdanpanahi N; Etemadifar M; Shams E
Iran J Neurol; 2019 Apr; 18(2):70-75. PubMed ID: 31565203
[No Abstract] [Full Text] [Related]
2. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the association between DNMT3B-579G>T polymorphism and cancer risk.
Xia Z; Duan F; Jing C; Guo Z; Nie C; Song C
Cancer Biomark; 2015; 15(5):707-16. PubMed ID: 26406961
[TBL] [Abstract][Full Text] [Related]
4. Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.
Lao Y; Wu H; Zhao C; Wu Q; Qiao F; Fan H
Biomed Rep; 2013 Sep; 1(5):771-775. PubMed ID: 24649027
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase 3B (DNMT3B -579G>T) promotor polymorphism and the susceptibility to pediatric immune thrombocytopenic purpura in Egypt.
Khorshied MM; El-Ghamrawy MK
Gene; 2012 Dec; 511(1):34-7. PubMed ID: 23000068
[TBL] [Abstract][Full Text] [Related]
6. DNA-methyltransferase 3B 39179 G > T polymorphism and risk of sporadic colorectal cancer in a subset of Iranian population.
Daraei A; Salehi R; Mohamadhashem F
J Res Med Sci; 2011 Jun; 16(6):807-13. PubMed ID: 22091311
[TBL] [Abstract][Full Text] [Related]
7. DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population.
Zhao H; Du W; Gu D; Wang D; Xue F; Ge J; Sui T; Yang R
Acta Haematol; 2009; 122(1):31-5. PubMed ID: 19696477
[TBL] [Abstract][Full Text] [Related]
8. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study.
Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK
Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965
[TBL] [Abstract][Full Text] [Related]
9. The DNMT3B -579G>T Polymorphism Is Significantly Associated With the Risk of Gastric Cancer but not Lung Cancer in Chinese Population.
Chen B; Wang J; Gu X; Zhang J; Zhang J; Feng X
Technol Cancer Res Treat; 2017 Dec; 16(6):1259-1265. PubMed ID: 29332452
[TBL] [Abstract][Full Text] [Related]
10. DNMT3B -149 C>T and -579 G>T Polymorphisms and Risk of Gastric and Colorectal Cancer: a Meta-analysis.
Khoram-Abadi KM; Forat-Yazdi M; Kheirandish S; Saeidi N; Zarezade Z; Mehrabi N; Neamatzadeh H
Asian Pac J Cancer Prev; 2016; 17(6):3015-20. PubMed ID: 27356727
[TBL] [Abstract][Full Text] [Related]
11. DNMT3B polymorphisms and risk of primary lung cancer.
Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.
Bao Q; He B; Pan Y; Tang Z; Zhang Y; Qu L; Xu Y; Zhu C; Tian F; Wang S
Int J Colorectal Dis; 2011 Sep; 26(9):1107-12. PubMed ID: 21519807
[TBL] [Abstract][Full Text] [Related]
13. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome.
Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L
Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874
[TBL] [Abstract][Full Text] [Related]
14. DNMT3B -579 G>T Promoter Polymorphism and the Risk of Gastric Cancer in the West of Iran.
Ahmadi K; Soleimani A; Irani S; Kiani A; Ghanadi K; Noormohamadi Z; Sakinejad F
J Gastrointest Cancer; 2018 Jun; 49(2):167-171. PubMed ID: 28220295
[TBL] [Abstract][Full Text] [Related]
15. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study.
Fan H; Zhang F; Hu J; Liu D; Zhao Z
J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374
[TBL] [Abstract][Full Text] [Related]
16. DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese.
Fan H; Liu DS; Zhang SH; Hu JB; Zhang F; Zhao ZJ
World J Gastroenterol; 2008 Apr; 14(14):2230-4. PubMed ID: 18407600
[TBL] [Abstract][Full Text] [Related]
17. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes.
Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S
Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer.
Wang C; Jia Z; Cao D; You L; Jin M; Wu X; Wen S; Cao X; Jiang J
PLoS One; 2015; 10(8):e0134059. PubMed ID: 26262893
[TBL] [Abstract][Full Text] [Related]
19. IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.
Bahari G; Hashemi M; Naderi M; Taheri M
Tumour Biol; 2016 Jul; 37(7):9579-86. PubMed ID: 26790447
[TBL] [Abstract][Full Text] [Related]
20. The DNMT3B -579 G>T promoter polymorphism and risk of lung cancer.
Liu H; Jiao Y; Guan Y; Lao Y; Zhao C; Fan H
Exp Ther Med; 2012 Mar; 3(3):525-529. PubMed ID: 22969923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
